Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention and treatment of acute altitude sickness by inhaled drugs
ChiCTR-IPR-16008441Phase 4Completed
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Jul 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of budesonide, salbutamol and Combivent in acute mountain sickness (AMS) (4 arms), sponsored by Southwest Hospital of Army Medical University. Primary endpoints: Incidence of acute mountain sickness, Hypertension and 2 more. Started Jul 2015; status: completed.
02
Drugs
budesonidesalbutamolCombivent
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on ChiCTR-IPR-16008441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008441.